ELIZABETH ROYSE: Open Payments
NPI 1851060800 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,642 in 72 payments from 22 companies in 2025. Trend: 2023 $142 · 2024 $1,740 · 2025 $1,642
Food & beverage: $1,642
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $377 |
| ABBVIE INC. | 16 | $280 |
| Novo Nordisk Inc | 10 | $168 |
| PFIZER INC. | 9 | $142 |
| Gilead Sciences, Inc. | 4 | $78 |
| Lilly USA, LLC | 4 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| ViiV Healthcare Company | 2 | $63 |
| Exact Sciences Corporation | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $51 |
Products named: FARXIGA, AIRSUPRA, UBRELVY, Wegovy, VRAYLAR, QULIPTA, NURTEC ODT, MOUNJARO.
Industry payments across OH — which companies pay providers there.
